Pimozide cf. Haloperidol in Tourette Syndrome

Abstract

Pimozide (3.4 mg/day) and haloperidol (3.5 mg/day) therapy for Tourette syndrome were compared in a double-blind, 24-week, placebo-controlled crossover study of 22 patients, aged 7-16 years, at the Institute of Psychiatry, Charleston, SC.

Keywords

• pimozide
• haloperidol
• tourette syndrome